Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|February 8, 2020
DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY StudyM Borgarelli, L Ferasin, K Lamb, et al.Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|June 12, 2021
The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY studyM Borgarelli, L Ferasin, K Lamb, et al.Journal of Veterinary Internal Medicine|July 22, 2008
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.Journal of Veterinary Internal Medicine|September 10, 2013
Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST studyJ Häggström, A Boswood, M O'Grady, et al.Journal of Veterinary Internal Medicine|September 29, 2016
Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical TrialA Boswood, J Häggström, S G Gordon, et al.Journal of Veterinary Internal Medicine|December 8, 2017
Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC StudyA Boswood, S G Gordon, J Häggström, et al.Journal of Veterinary Internal Medicine|March 23, 2020
Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC studyAdrian Boswood, Sonya G Gordon, Jens Häggström, et al.Journal of Veterinary Internal Medicine|April 17, 2018
International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL StudyPhilip R Fox, Bruce W Keene, Kenneth Lamb, et al.Pageof 8